Animal studies have documented an inhibition of tumor growth, as well as increased rates of apoptosis, as a result of NSCs that are genetically altered to express TRAIL in combination with other synergistic substances discussed below [78,79,80]. The gene discussed is TNFSF10; the disease is neoplasm.